日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Predictive Model for Surgical Approach Selection in Robotic Partial Nephrectomy and Its Perioperative Outcomes Based on Single-Center Retrospective Data

基于单中心回顾性数据的机器人辅助部分肾切除术手术入路选择及其围手术期结局预测模型

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70625
Shu, Fan; Liu, Zhuo; Duan, Peichen; Hao, Yichang; Ma, Xin; Zhang, Hongxian; Wang, Guoliang; Tian, Xiaojun; Liu, Lei; Zhang, Shudong
发表日期：2025
文献求助 收藏

Deficient DNA mismatch repair and Nectin-4 expression in upper tract urothelial carcinoma (UTUC).

上尿路尿路上皮癌 (UTUC) 中 DNA 错配修复缺陷和 Nectin-4 表达。

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06312-9
Duan Peichen, Yu Le, Hao Yichang, Deng Shaohui, Hong Peng, Lu Min, Zhang Shudong
肿瘤
发表日期：2025
文献求助 收藏

Clinical analysis of percutaneous kidney-sparing surgery for upper tract urothelial carcinoma

经皮肾脏保留手术治疗上尿路尿路上皮癌的临床分析

期刊:BMC Urology
影响因子:1.9
doi:10.1186/s12894-025-01980-8
Tang, Shiying; Liu, Zhuo; Xiao, Ruotao; Hao, Yichang; Qiu, Min; Zhang, Hongxian; Xiao, Chunlei; Zhang, Shudong
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy and safety of systemic treatment for progressive and refractory desmoid tumor: a systematic review and Bayesian network meta-analysis

系统治疗进展性难治性纤维瘤的疗效和安全性：系统评价和贝叶斯网络荟萃分析

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-024-01494-z
Ou, Junyong; Su, Dandan; Guan, Yunhe; Ge, Liyuan; Deng, Shaohui; Yan, Ye; Hao, Yichang; Lu, Min; Zhang, Shudong; Xie, Ruiyang
发表日期：2024
文献求助 收藏

Cystoscope-free ureteral stent removal: a safe and effective method during the COVID-19 pandemic

无需膀胱镜的输尿管支架取出术：新冠疫情期间一种安全有效的方法

期刊:American Journal of Clinical and Experimental Urology
影响因子:1.4
doi:10.62347/HSPG8492
Silang, Jiangcun; Gu, Yalong; Gazang, Ciren; Duan, Peichen; Tian, Xinlong; Luo, Feng; Wang, Jinlong; Zheng, Lei; Du, Zhiqiang; Yi, Hao; Wang, Feng; Hao, Yichang; Zhang, Baopeng
微生物学
新冠
发表日期：2024
文献求助 收藏

[Predicting the 3-year tumor-specific survival in patients with T(3a) non-metastatic renal cell carcinoma]

[预测T(3a)非转移性肾细胞癌患者的3年肿瘤特异性生存率]

期刊:Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
影响因子:
doi:10.19723/j.issn.1671-167X.2024.04.021
Zhou, Zezhen; Deng, Shaohui; Yan, Ye; Zhang, Fan; Hao, Yichang; Ge, Liyuan; Zhang, Hongxian; Wang, Guoliang; Zhang, Shudong
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2024
文献求助 收藏

The Significant Role of Tumor Volume on the Surgical Approach Choice, Surgical Complexity, and Postoperative Complications in Renal Cell Carcinoma With Venous Tumor Thrombus From a Large Chinese Center Experience

来自中国大型中心的经验：肿瘤体积对肾细胞癌合并静脉瘤栓的手术入路选择、手术复杂程度及术后并发症的显著影响

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.869891
Baheen, Qais; Liu, Zhuo; Hao, Yichang; Sawh, Rejean R R; Li, Yuxuan; Zhao, Xun; Hong, Peng; Wu, Zonglong; Ma, Lulin
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2022
文献求助 收藏

Case report and literature review: Primary leiomyosarcoma of the penis

病例报告及文献综述：阴茎原发性平滑肌肉瘤

期刊:Frontiers in Surgery
影响因子:1.8
doi:10.3389/fsurg.2022.1068935
Hao, Yichang; Xia, Li; Lu, Min; Liu, Chenhong; Zhang, Fan; Yan, Ye; Huang, Yi; Zhang, Shudong
发表日期：2022
文献求助 收藏

High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer

SMYD3高表达预示着膀胱癌患者预后不良，并通过IGF-1R/AKT/E2F-1正反馈环路促进肿瘤进展。

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.102718
Wang, Guoliang; Huang, Yi; Yang, Feilong; Tian, Xiaojun; Wang, Kun; Liu, Li; Fan, Yidong; Li, Xiaofeng; Li, Luchao; Shi, Benkang; Hao, Yichang; Xia, Chuanyou; Nie, Qingsheng; Xin, Yue; Shi, Zhenfeng; Ma, Lulin; Xu, Dawei; Liu, Cheng
肿瘤
SMYD3
肿瘤免疫
IGF-1
AKT
膀胱癌
发表日期：2020
文献求助 收藏